(Q33334839)
Statements
A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies (English)
Wong JYC
Chu DZ
Yamauchi DM
Williams LE
Liu A
Wilczynski S
Wu AM
Shively JE
Doroshow JH